77. Lauzardo M, Duncan H, Hale Y, Lee P. Transmission of Mycobacterium tuberculosis to a funeral director during routine embalming (abstract). American Journal of Respiratory and Critical Care Medicine 2000; 161:A299.

78. Price LE, Rutala WA, Samsa GP. Tuberculosis in hospital personnel. Infection Control 1987; 8:97–101.

79. Beck-Sague C, Dooley SW, Hutton MD, Otten J, Breeden A, Crawford JT, Pitchenik AE, Woodley C, Cauthen G, Jarvis WR. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients. Journal of the American Medical Association 1992; 268:1280–1286.

80. Panlilio AL, Burwen DR. Tuberculin skin testing surveillance of health-care workers (HCWS) (abstract). American Journal of Respiratory and Critical Care Medicine 1996; 153 (suppl):A133.

81. Sinkowitz RL, Fridkin SK, Managan L, Wenger PN, Jarvis WR. Status of tuberculosis infection control programs at United States Hospitals, 1989 to 1992. American Journal of Infection Control 1996; 24:226–234.

82. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Advances in Tuberculosis Research 1970; 17:28–106.

83. Myers JA, Bearman JE, Botkins AC. Natural history of tuberculosis in the human body. IX. Prognosis among students with tuberculin reaction conversion before, during and after medical school. Diseases of the Chest 1966; 50:120–132.

84. Myers JA, Bearman JE, Botkins AC. Natural history of tuberculosis in the human body. IX. Prognosis among students with tuberculin reaction conversion before, during and after school of nursing. Diseases of the Chest 1968; 53:687–698.

85. Sepkowitz KA. Tuberculin skin testing and the health care worker: lessons of the Prophit survey. Tuberculosis and Lung Disease 1996; 77:81–85.

86. Barrett-Connor E. The epidemiology of tuberculosis in physicians. Journal of the American Medical Association 1979; 241:33–38.

87. Edwards LB, Livesay VT, Acquaviva FA, Palmer CE. Height, weight, tuberculous infection, and tuberculous disease. Archives of Environmental Health 1971; 22:106–112.

88. Horwitz O, Wilbek E, Erickson PA. Epidemiologic basis of tuberculosis eradication. Bulletin of the World Health Organization 1969; 41:95–113.

89. Medical Research Council. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Bulletin World Health Organization 1972; 46:371–385.

90. Comstock GW. Community research in tuberculosis. Muscogee County, Georgia. Public Health Reports 1964; 79:1045–1056.

91. Comstock GW, Woolpert SH, Livesay VT. Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination. Public Health Reports 1976; 91:276–280.

92. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. American Journal of Epidemiology 1974; 99:131–138.

93. Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. American Review of Respiratory Diseases 1975; 111:573–577.

94. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. New England Journal of Medicine 1989; 320:545–550.

95. Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. Journal of the American Medical Association 1992; 268:504–509.

96. Di Perri G, Cruciani M, Danzi MC, Luzatti R, De Checchi G, Malena M, Pizzighella S, Mazzi R, Solbiati M, Concia E, Bassetti D. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 1989; 2:1502–1504.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement